News Industry News Essentials of Clinical Trial Design: Statistics 101 for the Budding Interventionalist May 13, 2021
News Industry News CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI October 17, 2020
News Industry News CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial June 01, 2020
News Industry News CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018 May 24, 2018
News Industry News NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR) August 30, 2017
News Industry News NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation April 26, 2017
News Industry News NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”) November 22, 2015